Background and Goal of Study: General anesthesia (GA) during carotid endarterectomy (CEA) requires a tight hemodynamic control in order to limit neurological and cardiovascular complications. This study aimed to demonstrate that the hemodynamic stability is bet ter respected with Xenon than with sevoflurane during CEA under GA in old patients. Materials and Methods: This randomized controlled trial was approved by our local ethic commit tee (CPP ParisVI). Patients older than 65 years scheduled for CEA were included. Anesthesia was induced in both groups with propofol and remifentanil and a non-depolarizing neuromuscular blocking agents (atracurium) was used for tracheal intubation. For the maintenance phase, patients were randomly allocated to either Xenon (60%) or Sevoflurane (1.7%). 30% of oxygen was used for all patients. Both groups received remifentanil targeted concentration of 2 ng/ml and adapted according to clinical needs and spontaneous EEG (BIS) monitoring. Continuous recording of arterial blood pressure (ABP), airway pressure and electrocardiogram was done (Biopac(tm)). Tachycardia, bradycardia, hyper and hypotension were defined as a change of more than 40% compared to the basal state recorded at rest before induction. Intraoperative hemodynamic variability was calculated using sequential analysis of one minute provided by the continuous recordings of ABP . Af ter integration over the time, hemodynamic variability was expressed as a continuous variable in %.min. Fisher exact test and non parametric Wilcoxon test were used to compare these endpoints. Results and Discussion: 46 old patients (mean age was 75 +/-7) were included in the two groups.
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[Hemodynamics comparisons]
Conclusion(s): GA for CEA conducted with Xenon reduced the time with hypotension and the use of vasopressors (phenylephrin or ephedrin) in old patients comparing to sevoflurane. This reduced frequency of hypotensive events was associated with less hemodynamic variability.
4AP2-3
Xenon reduces the gradient of blood pressures between radial blood pressure and occluded carotid artery during carotid endarterectomy: A randomized controlled study Le Manach Y., Cristina I., Gaudric J., Goarin J.P ., Fléron M.H., Coriat P .
GH. Pitié Salpétrière, Depar tment of Anaesthesiology and Intensive Care, Paris, France
Background and Goal of Study: During the cross clamping of the carotid required by Carotid endarterectomy (CEA), the brain circulation is mainly supplied by the controlateral carotid . A residual carotid blood pressure (RCBP) reflecting this can be measured. In this study we defined a gradiant of pressures (Gp), as the dif ference between the systemic arterial blood pressure (sABP) and the RCBP The aim of this randomized study was to compare this Gp during CEA conducted under general anesthesia (GA), with Sevoflurane(S) or Xenon(X).
Materials and Methods:
This randomized controlled trial was approved by our local ethic commit tee (CPP ParisVI). Patients older than 65 years scheduled for CEA were included. Anesthesia was induced in both groups with propofol and remifentanil. For the maintenance phase, patients were randomly allocated to either X (60%) or S (1.7%). Both groups received remifentanil targeted concentration of 2 ng/ml and adapted according to clinical needs and BIS monitoring. Continuous recording of systemic arterial blood pressure (sABP), and of RCBP was done (Biopac(tm)). RCBP was obtained by the placement, by the surgeon, of a Fogarty's probe in the carotid during the cross clamping. The primary endpoint, Gp, was calculated directly, and the means of these Gp over the time were compared using non parametric Wilcoxon test. Results and Discussion: 24 patients were included in this study, 12 in each group. No postoperative neurological adverse event has been observed. The mean cross clamping duration was 22 +/-5 minutes, and was not dif ferent in the groups. Mean Gp of the X Group was inferior (p< 0.001) compared to the one observed in the S group.
[ Figure ] Conclusions: The use of Xenon to conduct GA for CEA reduced the observed mean Gp during cross clamping compared to Sevoflurane. This suggests that X provides a bet ter regulation of the cross clamping than S. Nevertheless, these physiological observations need to be confirm by neurological outcomes.
4AP2-4
Propofol at tenuates apoptosis induced by angiotensin II via the PI3-kinase/Akt pathway in neonatal rat cardiomyocy tes ] was measured using indo-1 AM at λ ex 350 nm and λ em 395 and 456 nm in response to dif ferent concentrations of CaCl 2 in the presence or absence of MgCl 2 or isoflurane. Indo-1 signals were corrected for background fluorescence (NADH). Ψ m was measured using rhodamine-123. O 2 consumption was assessed using a Clark-2 type electrode during states 2-4 respiration, i.e. before, during and af ter adding 250 µM ADP . Results and Discussion: Adding 0.25 and 0.5 mM CaCl 2 to the buf fer containing 1 mM EGTA increased m[Ca 2+ ] in a dose-dependent manner at 0 MgCl 2 ; the presence of 0.5 and 2 mM MgCl 2 reduced the mCa 2+ -uptake in both groups. Adding 0.5 mM MgCl 2 did not increase m[Mg 2+ ], but 2 mM MgCl 2 increased m[Mg 2+ ] slowly from 0.35 to 0.55 mM over 10 min. State 3 respiration was not dif ferent among the 3 MgCl 2 groups, but state 4 was faster with added MgCl 2 . Isoflurane at 0.5 to 2 mM dose-dependently increased mCa 2+uptake despite a slight fall in ΔΨ m , but increased duration of state 3 respiration as well as the duration of the ADP-induced rise in m[Ca 2+ ]; moreover, isoflurane increased redox state (increased NADH), possibly by inhibiting complex I. Conclusions: Mg 2+ interferes with mCa 2+ -uptake via mCU whereas isoflurane enhances mCa 2+ uptake, possibly by modulating mCU function. Together, these factors appear to modulate mCa 2+ uptake and thereby alter mitochondrial function in dif ferent ways so that in health or disease a change in Mg 2+ may alter the mitochondrial ef fects of isoflurane.
4AP2-6
Genetic ef fects on propofol induced hypotension Chakithandy S., Anderson P . G., Wouters K.M., Arenas M., Lewis C.M., Morley A.P . Guy's and St. Thomas' NHS Foundation Trust, Depar tment of Anaesthesiology, London, United Kingdom Background and Goal of Study: Propofol-induced hypotension (PIH) may af fect postoperative outcome. 1 Its mechanism is unclear. We previously studied PIH in 262 ASA I-II Caucasian surgical patients aged 18-65 years, excluding diabetics, hypertensives and the obese. PIH was associated with weight and baseline mean arterial pressure (MAP). [2] [3] [4] In the current study, we aimed to establish the ef fect of selected genetic polymorphisms on PIH.
Materials and Methods:
We recruited 247 more patients using the same criteria. All 509 patients received intravenous propofol for 15 minutes in all, initially at 40mg/kg/h. When electroencephalographic bispectral index decreased to 50, propofol dose (PD) was recorded and infusion rate reduced to 8mg/ kg/h. Patients breathed facial oxygen at 4l/min. Non-invasive airway support was applied if needed. MAP was recorded every minute.
For each patient, we calculated the ma ximum percentage decrease from baseline MAP (ma x%ΔMAP) and then corrected for PD before testing for genetic association. The 155 patients at the upper (PIH sensitive) and lower (PIH resistant) tails of the distribution were selected for genotyping. DNA was extracted from blood samples.
Genotyping was conducted at the insertion/deletion polymorphism in the angiotensinogen converting enzyme gene (ACE In/Del) and four single nucleotide polymorphisms (genes): rs4961 (α adducin, ADD1), rs699 and rs5051 (angiotensin, AGT) and rs5186 (angiotensin II receptor type1, AGTR1). All have been associated with antihypertensive drug response. At each polymorphism, patient genotypes were coded 0,1 or 2, with 1 representing heterozygosity. Association of polymorphisms with PIH sensitive and PIH resistant groups was tested with a linear model. Results and Discussion: Mean (SD) ma x%ΔMAP was 32.2(3.7)% and 17.4(4.7) % in PIH sensitive and PIH resistant groups respectively. Genotype frequencies did not dif fer significantly between groups. P values for each polymorphism were: ACE In/Del = 0.27, rs4961 = 0.65, rs699 = 0.37, rs5051 = 0.26, rs5186 = 0.07. Conclusion: These polymorphisms do not strongly af fect PIH. This does not preclude ef fects of other polymorphisms on PIH in these or other genes.
References:
( 
